![]() |
Volumn 31, Issue 3, 2006, Pages 259-
|
The BASKET-LATE study: Basel stent cost-effectiveness trial - late thrombotic events trial;Die BASKET-LATE-studie. Basel stent cost-effectiveness trial-late thrombotic events trial
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
MAGNESIUM;
ANGIOGRAPHY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
IMPLANTATION;
NOTE;
PERCUTANEOUS CORONARY INTERVENTION;
RANDOMIZED CONTROLLED TRIAL;
STENT;
THROMBOSIS;
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
MALE;
RISK ASSESSMENT;
RISK FACTORS;
STENTS;
SWITZERLAND;
THROMBOSIS;
|
EID: 33745129402
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: 10.1007/s00059-006-2828-4 Document Type: Note |
Times cited : (12)
|
References (0)
|